Serum hepatitis B core antibody as a biomarker of hepatic inflammation in chronic hepatitis B patients with normal alanine aminotransferase

Abstract Our previous studies unexpectedly indicated that the level of serum hepatitis B core antibody (anti-HBc) was positively correlated with the serum alanine aminotransferase (ALT) level. The aim of this study was to determine whether anti-HBc could serve as a potential biomarker for the detect...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jiyuan Zhou, Liuwei Song, Hong Zhao, Linlin Yan, Anlin Ma, Shibin Xie, Xuqing Zhang, Dazhi Zhang, Qing Xie, Guo Zhang, Jia Shang, Jun Cheng, Weifeng Zhao, Zhiqiang Zou, Mingxiang Zhang, Ningshao Xia, Guiqiang Wang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/e8c68542a267458287b8868a1a7e39f3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e8c68542a267458287b8868a1a7e39f3
record_format dspace
spelling oai:doaj.org-article:e8c68542a267458287b8868a1a7e39f32021-12-02T15:05:56ZSerum hepatitis B core antibody as a biomarker of hepatic inflammation in chronic hepatitis B patients with normal alanine aminotransferase10.1038/s41598-017-03102-32045-2322https://doaj.org/article/e8c68542a267458287b8868a1a7e39f32017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-03102-3https://doaj.org/toc/2045-2322Abstract Our previous studies unexpectedly indicated that the level of serum hepatitis B core antibody (anti-HBc) was positively correlated with the serum alanine aminotransferase (ALT) level. The aim of this study was to determine whether anti-HBc could serve as a potential biomarker for the detection of liver inflammation in chronic hepatitis B (CHB) patients, especially in patients with normal ALT levels. Serum anti-HBc levels were quantified in 655 treatment-naïve CHB patients, including 45 patients who underwent two liver biopsies (baseline phase and the 78th weeks of antiviral-treatment). Serum anti-HBc levels increased significantly along with the increasing histology activity index (HAI) score. After antiviral-treatment, patients with HAI score reduction had significant decline in serum anti-HBc level. Multivariate analysis showed that anti-HBc was independently associated with moderate-to-severe hepatic inflammation in patients with normal ALT level. Furthermore, serum anti-HBc showed a high diagnostic accuracy for predicting moderate-to-severe inflammation in both hepatitis B e antigen (HBeAg)-positive and HBeAg-negative CHB patients with normal ALT levels (area under the curve, AUC = 0.87 and 0.75; respectively). Thus, anti-HBc may be a strong indicator for assessing the hepatic inflammatory degree and used for antiviral treatment decisions in CHB patients with normal ALT levels.Jiyuan ZhouLiuwei SongHong ZhaoLinlin YanAnlin MaShibin XieXuqing ZhangDazhi ZhangQing XieGuo ZhangJia ShangJun ChengWeifeng ZhaoZhiqiang ZouMingxiang ZhangNingshao XiaGuiqiang WangNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jiyuan Zhou
Liuwei Song
Hong Zhao
Linlin Yan
Anlin Ma
Shibin Xie
Xuqing Zhang
Dazhi Zhang
Qing Xie
Guo Zhang
Jia Shang
Jun Cheng
Weifeng Zhao
Zhiqiang Zou
Mingxiang Zhang
Ningshao Xia
Guiqiang Wang
Serum hepatitis B core antibody as a biomarker of hepatic inflammation in chronic hepatitis B patients with normal alanine aminotransferase
description Abstract Our previous studies unexpectedly indicated that the level of serum hepatitis B core antibody (anti-HBc) was positively correlated with the serum alanine aminotransferase (ALT) level. The aim of this study was to determine whether anti-HBc could serve as a potential biomarker for the detection of liver inflammation in chronic hepatitis B (CHB) patients, especially in patients with normal ALT levels. Serum anti-HBc levels were quantified in 655 treatment-naïve CHB patients, including 45 patients who underwent two liver biopsies (baseline phase and the 78th weeks of antiviral-treatment). Serum anti-HBc levels increased significantly along with the increasing histology activity index (HAI) score. After antiviral-treatment, patients with HAI score reduction had significant decline in serum anti-HBc level. Multivariate analysis showed that anti-HBc was independently associated with moderate-to-severe hepatic inflammation in patients with normal ALT level. Furthermore, serum anti-HBc showed a high diagnostic accuracy for predicting moderate-to-severe inflammation in both hepatitis B e antigen (HBeAg)-positive and HBeAg-negative CHB patients with normal ALT levels (area under the curve, AUC = 0.87 and 0.75; respectively). Thus, anti-HBc may be a strong indicator for assessing the hepatic inflammatory degree and used for antiviral treatment decisions in CHB patients with normal ALT levels.
format article
author Jiyuan Zhou
Liuwei Song
Hong Zhao
Linlin Yan
Anlin Ma
Shibin Xie
Xuqing Zhang
Dazhi Zhang
Qing Xie
Guo Zhang
Jia Shang
Jun Cheng
Weifeng Zhao
Zhiqiang Zou
Mingxiang Zhang
Ningshao Xia
Guiqiang Wang
author_facet Jiyuan Zhou
Liuwei Song
Hong Zhao
Linlin Yan
Anlin Ma
Shibin Xie
Xuqing Zhang
Dazhi Zhang
Qing Xie
Guo Zhang
Jia Shang
Jun Cheng
Weifeng Zhao
Zhiqiang Zou
Mingxiang Zhang
Ningshao Xia
Guiqiang Wang
author_sort Jiyuan Zhou
title Serum hepatitis B core antibody as a biomarker of hepatic inflammation in chronic hepatitis B patients with normal alanine aminotransferase
title_short Serum hepatitis B core antibody as a biomarker of hepatic inflammation in chronic hepatitis B patients with normal alanine aminotransferase
title_full Serum hepatitis B core antibody as a biomarker of hepatic inflammation in chronic hepatitis B patients with normal alanine aminotransferase
title_fullStr Serum hepatitis B core antibody as a biomarker of hepatic inflammation in chronic hepatitis B patients with normal alanine aminotransferase
title_full_unstemmed Serum hepatitis B core antibody as a biomarker of hepatic inflammation in chronic hepatitis B patients with normal alanine aminotransferase
title_sort serum hepatitis b core antibody as a biomarker of hepatic inflammation in chronic hepatitis b patients with normal alanine aminotransferase
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/e8c68542a267458287b8868a1a7e39f3
work_keys_str_mv AT jiyuanzhou serumhepatitisbcoreantibodyasabiomarkerofhepaticinflammationinchronichepatitisbpatientswithnormalalanineaminotransferase
AT liuweisong serumhepatitisbcoreantibodyasabiomarkerofhepaticinflammationinchronichepatitisbpatientswithnormalalanineaminotransferase
AT hongzhao serumhepatitisbcoreantibodyasabiomarkerofhepaticinflammationinchronichepatitisbpatientswithnormalalanineaminotransferase
AT linlinyan serumhepatitisbcoreantibodyasabiomarkerofhepaticinflammationinchronichepatitisbpatientswithnormalalanineaminotransferase
AT anlinma serumhepatitisbcoreantibodyasabiomarkerofhepaticinflammationinchronichepatitisbpatientswithnormalalanineaminotransferase
AT shibinxie serumhepatitisbcoreantibodyasabiomarkerofhepaticinflammationinchronichepatitisbpatientswithnormalalanineaminotransferase
AT xuqingzhang serumhepatitisbcoreantibodyasabiomarkerofhepaticinflammationinchronichepatitisbpatientswithnormalalanineaminotransferase
AT dazhizhang serumhepatitisbcoreantibodyasabiomarkerofhepaticinflammationinchronichepatitisbpatientswithnormalalanineaminotransferase
AT qingxie serumhepatitisbcoreantibodyasabiomarkerofhepaticinflammationinchronichepatitisbpatientswithnormalalanineaminotransferase
AT guozhang serumhepatitisbcoreantibodyasabiomarkerofhepaticinflammationinchronichepatitisbpatientswithnormalalanineaminotransferase
AT jiashang serumhepatitisbcoreantibodyasabiomarkerofhepaticinflammationinchronichepatitisbpatientswithnormalalanineaminotransferase
AT juncheng serumhepatitisbcoreantibodyasabiomarkerofhepaticinflammationinchronichepatitisbpatientswithnormalalanineaminotransferase
AT weifengzhao serumhepatitisbcoreantibodyasabiomarkerofhepaticinflammationinchronichepatitisbpatientswithnormalalanineaminotransferase
AT zhiqiangzou serumhepatitisbcoreantibodyasabiomarkerofhepaticinflammationinchronichepatitisbpatientswithnormalalanineaminotransferase
AT mingxiangzhang serumhepatitisbcoreantibodyasabiomarkerofhepaticinflammationinchronichepatitisbpatientswithnormalalanineaminotransferase
AT ningshaoxia serumhepatitisbcoreantibodyasabiomarkerofhepaticinflammationinchronichepatitisbpatientswithnormalalanineaminotransferase
AT guiqiangwang serumhepatitisbcoreantibodyasabiomarkerofhepaticinflammationinchronichepatitisbpatientswithnormalalanineaminotransferase
_version_ 1718388677991727104